Excelsior Biopharma Inc. (TPEX:6496)

Taiwan · Delayed Price · Currency is TWD

27.05

+0.55 (2.08%)

Mar 6, 2026, 12:14 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	898.26M	861.91M	771.56M	671.76M	1.34B
Pharmaceuticals Growth	4.22%	11.71%	14.86%	-49.81%	-7.29%
Total	898.26M	861.91M	771.56M	671.76M	1.34B
Total Growth	4.22%	11.71%	14.86%	-49.81%	-7.29%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	797.79M	722.07M	637.96M	1.30B
Taiwan Growth	10.49%	13.18%	-50.80%	-7.64%
China	56.60M	48.40M	33.62M	40.96M
China Growth	16.93%	43.99%	-17.92%	6.76%
Others	7.53M	1.08M	184.00K	831.00K
Others Growth	594.28%	489.13%	-77.86%	-39.65%
Total	861.91M	771.56M	671.76M	1.34B
Total Growth	11.71%	14.86%	-49.81%	-7.29%

Source: S&P Global Market Intelligence.